Article
PCAT: An integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models
2020-06-23
Abstract excerpt
Although cancer is the leading cause of disease-related mortality in children, the relative rarity of pediatric cancers poses a significant challenge for developing novel therapeutics to further improve prognosis. Patient-derived xenograft (PDX) models, which are usually developed from high-risk tumors, are a useful platform to study molecular driver events, identify biomarkers, and prioritize therapeutic agents....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 205d6a95-58f9-52f6-9a7e-2066016cf3e5
- DOI
- 10.1101/2020.06.22.165282
